Patent US4235962A successfully refreshed from Google Patents.
Patent US3532759A successfully refreshed from Google Patents.
← Back to Patent Explorer
EP0185404A1 Expired / Lapsed EP ⏱️ 0.0 years remaining

Stroma-free hemoglobin solution, process for the preparation thereof and its application

Assignee: EURO-TROL B.V.
•
Filing: 1985-11-08
•
Granted: —
•
Expires: 2005-11-08
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Hemoglobin solution is stabilized by adding inositol hexaphosphate to give a molar ratio IHP/HB of from 0.1:1 to 1:1 by preference reduced NAD is also added. The stabilized solution is l.A. suitable for calibrating blood-gas control apparatus.

Inventors

  • 👤 Ronald Sprokholt
  • 👤 Antonius Henricus Josephus Maas

Bibliographic Details

Application Number —
Jurisdiction EP
Data Source google_patents
Last Synchronized 2026-11-04 03:29
CPC Classifications
G; G01; G01N; G01N33/00; G01N33/48; G01N33/50; G01N33/96; C; C07; C07K; C07K14/00; C07K14/795; C07K14/805; A; A61; A61M; A61M1/00; A61M1/36; A61M1/3693; A61M2202/00; A61M2202/04; A61M2202/0413; A61M2202/0429; A61M2202/0433; G01N2333/00; G01N2333/795; G01N2333/805; G01N2496/00; G01N2496/70; G01N2496/80; G01N33/72

Claims Analysis

Total Claims: 14
Claim 1
Independent Claim 24 words
STROMA-FREE HEMOGLOBIN SOLUTION, CHARACTERIZED IN THAT IT CONTAINS INOSITOL HEXAPHOSPHATE, IN SUCH AN AMOUNT THAT THE MOLAR RATIO IHP/HB IS FROM 0.1:1 TO 1.0:1.
Claim 2
Dependent Claim 24 words
STROMA-FREE HEMOGLOBIN SOLUTION, CHARACTERIZED IN THAT IT CONTAINS INOSITOL HEXAPHOSPHATE, IN SUCH AN AMOUNT THAT THE MOLAR RATIO IHP/HB IS FROM 0.1:1 TO 1.0:1.
Claim 3
Dependent Claim 18 words
STOMA-FREE HEMOGLOBIN-SOLUTION ACCORDING TO CLAIM 1 CHARACTERIZED IN THAT IT ALSO CONTAINS METHEMOGLOBIN REDUCTASE AND REDUCED NAD (NADH).
Claim 4
Dependent Claim 15 words
STROMA-FREE HEMOGLOBIN SOLUTION ACCORDING TO CLAIM 2, CHARACTERIZED IN THAT IT ALSO CONTAINS CYCTOCHROME B5.
Claim 5
Dependent Claim 28 words
STROMA-FREE HEMOGLOBIN SOLUTION ACCORDING TO ANY OF THE PRECEDING CLAIMS, CHARACTERIZED IN THAT IT CONTAINS FROM 3 TO 15 MMOL/LHB AND HAS A PH FROM 6,9 TO 8,1.
Claim 6
Dependent Claim 27 words
STROMA-FREE HEMOGLOBIN SOLUTION ACCORDING TO ANY OF THE PRECEDING CLAIMS, CHARACTERIZED IN THAT AFTER BEING KEPT FOR 1 YEAR AT BELOW 4°C IT STILL CONTAINS NO PRECIPITATE.
Claim 7
Dependent Claim 14 words
STROMA-FREE HEMOGLOBIN COMPOSITION ACCORDING TO ANY OF THE PRECEDING CLAIMS CONSISTING OF THREE SOLUTIONS,
Claim 8
Dependent Claim 11 words
WITH A PH OF ABOUT 7.2, ABOUT 7.4 AND ABOUT 7.6.
Claim 9
Dependent Claim 11 words
WITH A PH OF ABOUT 7.2, ABOUT 7.4 AND ABOUT 7.6.
Claim 10
Dependent Claim 85 words
PROCESS FOR PREPARING A STROMA-FREE HEMOGLOBIN-SOLUTION, WHEREIN PREVIOUSLY PURIFIED ERYTHOCYTES ARE LYSED BY ADDING DISTILLED OR DEMINERALIZED WATER AND IN THE LYSATE THE CONTENTS OF CA; NA; K; HCO 3 AND CL' ARE ADJUSTED AT THE VALUES CORRESPONDING WITH THOSE OF BLOOD PLASMA, BY GASSING THE PCO 2 AND PO 2 ARE ADJUSTED AT THE DESIRED VALUES, AND THE FINAL COMPOSITION IS STERILIZED BY FILTERING, CHARACTERIZED IN THAT MOREOVER SO MUCH INOSITOL HEXAPHOSPHATE IS ADDED THAT THE MOLAR RATIO IHP/HB IS FROM 0.1:1 TO 1.0:1.
Claim 11
Dependent Claim 85 words
PROCESS FOR PREPARING A STROMA-FREE HEMOGLOBIN-SOLUTION, WHEREIN PREVIOUSLY PURIFIED ERYTHOCYTES ARE LYSED BY ADDING DISTILLED OR DEMINERALIZED WATER AND IN THE LYSATE THE CONTENTS OF CA; NA; K; HCO 3 AND CL' ARE ADJUSTED AT THE VALUES CORRESPONDING WITH THOSE OF BLOOD PLASMA, BY GASSING THE PCO 2 AND PO 2 ARE ADJUSTED AT THE DESIRED VALUES, AND THE FINAL COMPOSITION IS STERILIZED BY FILTERING, CHARACTERIZED IN THAT MOREOVER SO MUCH INOSITOL HEXAPHOSPHATE IS ADDED THAT THE MOLAR RATIO IHP/HB IS FROM 0.1:1 TO 1.0:1.
Claim 12
Dependent Claim 88 words
PROCESS ACCORDING TO CLAIM 7, CHARACTERIZED IN THAT TO THE LYSATE SO MUCH IHP IS ADDED, THAT THE MOLAR RATIO IHP/HB IS ABOUT 0.5:1, THE PH IS ADJUSTED BETWEEN 8.0 AND 8.1 WITH DILUTED NAOH, THE PRECIPITATE IS REMOVED BY CENTRIFUGING. THE PH ADJUSTED BETWEEN 6.9 AND 7.0 WITH DILUTED HCL, THE PRECIPITATE IS REMOVED BY CENTRIFUGING, AND FINALLY AFTER ADDITION OF CA; K', NA', HCO 3 AND CL' TO ATTAIN THE DESIRED CONTENTS, THE PH AND PCO 2 AND P0 2 ARE ADJUSTED AT THE DESIRED VALUES.
Claim 13
Dependent Claim 30 words
PROCESS FOR DETERMINING PH, PCO 2 ' P0 2 AND/OR HB IN BLOOD, CHARACTERIZED IN THAT SAID DETERMINATION IS CALIBRATED WITH A SOLUTION OBTAINED ACCORDING TO ANY OF CLAIMS 1-6.
Claim 14
Dependent Claim 13 words
APPLICATION OF A COMPOSITION ACCORDING TO ANY OF CLAIMS 1-6 AS BLOOD SUBSTITUTE.

References Cited (Backward Citations)

EP0001104A2 Cited
US4358394A Cited
EP0071888A2 Cited
EP0078961A2 Cited
EP0158684A1 Cited

USPTO Annuity & Maintenance Windows

Maintenance schedule is calculated for granted US utility patents.

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag